Join our daily newsletter At The Bell to receive exclusive market insights
- Nutrition and wellness company Eve Investments (EVE) has received an initial $2.4 million backing from two companies
- Sydney-based Everhoney and Hong Kong’s Jusheng Bolang bought into the company at 0.5 cents per share
- In the next three months, a second raise is expected to generate nearly $6.9 million
- The company says it is using the funds to build up its Meluka brand inventory which includes honey, essential oils and a bio-fermented honey drink
- Eve’s share price is remaining flat today, with shares trading for 0.5 cents each
Nutrition and wellness company Eve Investments (EVE) has received a multi-million dollar backing from two companies, Everhoney and Jusheng Bolang.
The two companies have committed an initial $2.4 million under a first subscription fund. This was raised through the issue of shares at 0.5 cents each.
Within three months a second subscription will take place raising nearly an additional $6.9 million. Shares will be issued at one cent each.
Everhoney is a Sydney-based investment group which specialises in the agricultural, health and nutrition sectors. Jusheng Bolang is international trading enterprise, with a focus on health products, operating in Hong Kong.
Eve advised the raised funds will be used to build up the inventory of its Meluka products which include: honey, essential oils and a new bio-fermented honey drink.
Once the product base is up, Eve explained it will focus on sales in the Chinese, U.S. and Australian market.
In today’s release to the market, Eve wrote: “The product build has already commenced with manufacturing continuing and shipments expected to commence in late-December.”
Upon resuming trade after its voluntary suspension, Eve’s share price has remained flat on the Australian market today. Shares in the company are currently worth 0.5 cents each.
